Table 3.
BCL-XL Degraders Designed with Various Linkers Tethering through a Piperazine Ring to Pomalidomide
![]() |
|||||
|---|---|---|---|---|---|
| Compd | Linker | IC50 (nM)a | Compd | Linker | IC50 (nM)a |
| 8a | ![]() |
82.0 | 10a | 161 | |
| 8b | ![]() |
346 | 10b | 211 | |
| 8c | ![]() |
518 | 10c | 126 | |
| 8d | ![]() |
>2000 | 11a | 118 | |
| 8e | >2000 | 11b | 722 | ||
| 9a | ![]() |
28.3 | 12a | 60.5 | |
| 9b | ![]() |
43.0 | 12b | 41.4 | |
| 9c | 100 | 12c | 17.3 | ||
IC50 values are the means of at least three independent experiments; reduction of MOLT-4 cell viability after 48 h treatment.






